Professional Media briefs: June 2013

Professional Media briefs: June 2013
Professional Media briefs: June 2013

Oxford University Press has launched the online-only open-access Gastroenterology Report, which it co-owns with Digestive Science Publishing. The journal is based in China, where the publisher says gastroenterology research has taken off. Managing editor Tim Wang said in a statement that China “is facing challenges to publish high-tier medical journals with international audiences.”

The first interactive mobile version of Barash's Clinical Anesthesia went live in April. Published by Lippincott Williams and Wilkins, the access package includes iPad and iPhone entry points, plus online desktop access and the print edition. The publisher said content is updated twice a month. Download-only purchase and the all-in-one kit cost the same: $229.99.

UBM Medica sealed an exclusive distribution partnership with Ultrasound-Images.com. The collaboration provides free access to a gallery of ultrasound, color Doppler and 3-D images from radiologists and sonographers. Images include labels and links and supporting videos when available. The partnership will offer advertisers “greater reach into the imaging marketplace” UBM senior director Barron Hirsh said in a statement.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.